Dechra Pharmaceuticals shares rise as board agrees takeover bid
EQT trims bid price on lowered outlookSwedish investor a specialist in healthcarePrice still represents a 44% premiumShares in FTSE 250 veterinary drug maker Dechra Pharmaceuticals (DPH) gained 8% to £36.45 after the firm agreed a...
02 June 2023
